Dr. Ronald A Sparschu, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3273 Davison Rd Ste 3, Lapeer, MI 48446 Phone: 810-245-5675 Fax: 810-235-6650 |
Reese James, D.O. Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 1375 N Main St, Lapeer, MI 48446 Phone: 810-667-5744 Fax: 810-667-5741 |
Leighton Ms Lum, DO Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1375 N Main St, Lapeer, MI 48446 Phone: 810-667-5500 |
Donna R Moyer, DO Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1375 N Main St, Lapeer, MI 48446 Phone: 810-667-5500 |
Mr. Eduard Volfovitch Kotlyarov, MD Radiology - Nuclear Radiology Medicare: Medicare Enrolled Practice Location: 1375 N Main St, Lapeer, MI 48446 Phone: 810-667-5500 |
News Archive
A new study from UBC researchers finds that teens, especially girls, have better mental health when they spend more time taking part in extracurricular activities, like sports and art, and less time in front of screens.
Dr. Ed Ruthazer is a mapmaker but, his landscape is the developing brain - specifically the neuronal circuitry, which is the network of connections between nerve cells. His research at The Montreal Neurological Institute and Hospital - The Neuro at McGill University, reveals the brain as a dynamic landscape where connections between nerves are plastic, changing and adapting to the demands of the environment.
Young adults are at particularly high risk for excessive weight gain. Although weight gain intervention for young adults attending two- or four-year colleges has been studied extensively, there has been little research into effective weight management programs targeting low-income, non-college bound young adults.
MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a randomized Phase II clinical trial of its lead investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS).
› Verified 3 days ago